Literature DB >> 32126170

Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism.

José Rogério A Silva1, Lorenzo Cianni2, Deborah Araujo2, Pedro Henrique Jatai Batista2, Daniela de Vita2, Fabiana Rosini2, Andrei Leitão2, Jerônimo Lameira1, Carlos A Montanari2.   

Abstract

Reversible and irreversible covalent ligands are advanced cysteine protease inhibitors in the drug development pipeline. K777 is an irreversible inhibitor of cruzain, a necessary enzyme for the survival of the Trypanosoma cruzi (T. cruzi) parasite, the causative agent of Chagas disease. Despite their importance, irreversible covalent inhibitors are still often avoided due to the risk of adverse effects. Herein, we replaced the K777 vinyl sulfone group with a nitrile moiety to obtain a reversible covalent inhibitor (Neq0682) of cysteine protease. Then, we used advanced experimental and computational techniques to explore details of the inhibition mechanism of cruzain by reversible and irreversible inhibitors. The isothermal titration calorimetry (ITC) analysis shows that inhibition of cruzain by an irreversible inhibitor is thermodynamically more favorable than by a reversible one. The hybrid Quantum Mechanics/Molecular Mechanics (QM/MM) and Molecular Dynamics (MD) simulations were used to explore the mechanism of the reaction inhibition of cruzain by K777 and Neq0682. The calculated free energy profiles show that the Cys25 nucleophilic attack and His162 proton transfer occur in a single step for a reversible inhibitor and two steps for an irreversible covalent inhibitor. The hybrid QM/MM calculated free energies for the inhibition reaction correspond to -26.7 and -5.9 kcal mol-1 for K777 and Neq0682 at the MP2/MM level, respectively. These results indicate that the ΔG of the reaction is very negative for the process involving K777, consequently, the covalent adduct cannot revert to a noncovalent protein-ligand complex, and its binding tends to be irreversible. Overall, the present study provides insights into a covalent inhibition mechanism of cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32126170     DOI: 10.1021/acs.jcim.9b01138

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  10 in total

1.  Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency.

Authors:  Francesca Galvani; Laura Scalvini; Silvia Rivara; Alessio Lodola; Marco Mor
Journal:  J Chem Inf Model       Date:  2022-05-17       Impact factor: 6.162

2.  On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.

Authors:  Vinicius Bonatto; Pedro Henrique Jatai Batista; Lorenzo Cianni; Daniela De Vita; Daniel G Silva; Rodrigo Cedron; Daiane Y Tezuka; Sérgio de Albuquerque; Carolina Borsoi Moraes; Caio Haddad Franco; Jerônimo Lameira; Andrei Leitão; Carlos A Montanari
Journal:  RSC Med Chem       Date:  2020-09-09

3.  Evaluating the Performance of a Non-Bonded Cu2+ Model Including Jahn-Teller Effect into the Binding of Tyrosinase Inhibitors.

Authors:  Lucas Sousa Martins; Jerônimo Lameira; Hendrik G Kruger; Cláudio Nahum Alves; José Rogério A Silva
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

4.  On the Catalytic Activity of the Engineered Coiled-Coil Heptamer Mimicking the Hydrolase Enzymes: Insights from a Computational Study.

Authors:  Mario Prejanò; Isabella Romeo; Nino Russo; Tiziana Marino
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

Review 5.  Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies.

Authors:  Brigitta Elsässer; Peter Goettig
Journal:  Int J Mol Sci       Date:  2021-03-22       Impact factor: 5.923

Review 6.  Computational approaches towards the discovery and optimisation of cruzain inhibitors.

Authors:  Viviane Corrêa Santos; Rafaela Salgado Ferreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-16       Impact factor: 2.743

Review 7.  Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.

Authors:  Simone Brogi; Roberta Ibba; Sara Rossi; Stefania Butini; Vincenzo Calderone; Sandra Gemma; Giuseppe Campiani
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

8.  Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.

Authors:  Kemel Arafet; Natalia Serrano-Aparicio; Alessio Lodola; Adrian J Mulholland; Florenci V González; Katarzyna Świderek; Vicent Moliner
Journal:  Chem Sci       Date:  2020-11-27       Impact factor: 9.825

9.  Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM/MM computational methods.

Authors:  Katarzyna Świderek; Vicent Moliner
Journal:  Chem Sci       Date:  2020-06-25       Impact factor: 9.825

10.  Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2.

Authors:  A V Nemukhin; B L Grigorenko; S V Lushchekina; S D Varfolomeev
Journal:  Russ Chem Bull       Date:  2022-01-15       Impact factor: 1.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.